Synaptogenix, Inc. (NASDAQ:SNPX – Get Free Report)’s share price traded down 4.2% during mid-day trading on Tuesday . The company traded as low as $5.75 and last traded at $5.95. 253,530 shares changed hands during trading, an increase of 1% from the average session volume of 250,819 shares. The stock had previously closed at $6.21.
Synaptogenix Trading Down 4.2%
The company has a market cap of $8.27 million, a P/E ratio of -0.59 and a beta of 1.08. The business has a 50 day moving average price of $7.37 and a 200-day moving average price of $4.61.
Synaptogenix Company Profile
Synaptogenix, Inc operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It also evaluates therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease.
Featured Stories
- Five stocks we like better than Synaptogenix
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Is It Time to Trim Your Positions in These 2 AI Stocks?
- What is a Stock Market Index and How Do You Use Them?
- These 3 Tech Stocks Just Supercharged Their Buybacks
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 3 Dividend Stocks to Hold Through Market Volatility This Fall
Receive News & Ratings for Synaptogenix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synaptogenix and related companies with MarketBeat.com's FREE daily email newsletter.
